Share Name Share Symbol Market Type
ANI Pharmaceuticals Inc NASDAQ:ANIP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.91 -7.16% 37.76 32.50 80.00 41.01 36.91 39.32 93,132 20:30:00

ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-to-Date 2019 Financial Results

20/02/2020 1:30pm

PR Newswire (US)

ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart

2 Months : From Jan 2020 to Mar 2020

Click Here for more ANI Pharmaceuticals Charts.

BAUDETTE, Minn., Feb. 20, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its fourth quarter and year-to-date 2019 financial results on Thursday, February 27, 2020, before the opening of the U.S. financial markets. The earnings press release will be accessible through the Investor Relations section of the Company's website,

Arthur S. Przybyl, President and Chief Executive Officer, and Stephen P. Carey, Vice President, Finance, and Chief Financial Officer, also plan to host a conference call to review those results starting at 10:30am Eastern Time on Thursday, February 27, 2020. The call will be open to the public and can be accessed through a conference line by dialing (866) 776-8875. The conference ID is 4783883.

A recording of the conference call will be available within two hours of the completion of the call and will remain accessible for a period of seven days following the call. To access the replay, dial (800) 585-8367. The access code for the replay is 4783883.

About ANI

ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. The Company's targeted areas of product development currently include controlled substances, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products. For more information, please visit our website

For more information about ANI, please contact:
Investor Relations


Cision View original content:

SOURCE ANI Pharmaceuticals, Inc.

Copyright 2020 PR Newswire

1 Year ANI Pharmaceuticals Chart

1 Year ANI Pharmaceuticals Chart

1 Month ANI Pharmaceuticals Chart

1 Month ANI Pharmaceuticals Chart
ADVFN Advertorial
Your Recent History
ANI Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200329 23:04:07